Concepedia

Elizabeth O. Hexner

EO

Statistics

Publications

137

Citations

13.9K

H-Index

55

Active since

2004

Affiliations

University of Pennsylvania(Current)

University of Michigan

Icahn School of Medicine at Mount Sinai

The University of Texas MD Anderson Cancer Center

Emory University

Elizabeth O. Hexner is an author at University of Pennsylvania specializing in medicine, life sciences, and immunology.

ORCID

Publications per year

2004–2025

137

Publications

137

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

, , +12

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

, , +17

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung et al. · Nature Medicine · 2022 · 500 citations · Full text

, , +14

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George et al. · New England Journal of Medicine · 2016 · 478 citations · Full text

, , +16

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Srđan Verstovšek, Ruben A. Mesa, Jason Gotlib et al. · Journal of Hematology & Oncology · 2017 · 427 citations · Full text

, , +10

1–5 of 137